The Institute for Democratic Engagement and Accountability (IDEA) and the Division of Bioethics invite you to celebrate the publication of Regulating the Revolution: Democratic Deliberation and Biotechnology (University of North Carolina Press, 2026) by Naomi Scheinerman.
The book uses CRISPR-Cas9, the gene-editing tool discovered in 2012, as a case study. Scheinerman argues that ordinary people should take part in democratic deliberation when government agencies write the rules for new technologies. She proposes a framework that draws on the authority of both experts and non-experts and connects how markets are regulated to broader goals of justice and equality.
The afternoon opens at 3 p.m. with cake and conversation. At 3:30 p.m., Michael Neblo, director of IDEA, will moderate a conversation with Scheinerman about the book, followed by a response from Dana Howard, assistant professor in the Division of Bioethics.
Seating is limited to 40. The first 10 people to register will be entered in a drawing for one of two free copies of the book.
About the author
Naomi Scheinerman is an assistant professor of bioethics in the Department of Biomedical Education and Anatomy at The Ohio State University College of Medicine and associated faculty with IDEA. Her research looks at how democratic deliberation can help regulate new technologies, including gene editing, prenatal testing, and newborn screening. She holds a PhD in political science from Yale University.